EU agriculture ministers want to exclude crops created by targeted mutation methods from EU GMO legislation.
Spotlight: Proactive Biomarker Planning to Optimize Clinical Trials
Oncology drugs developed through a biomarker-guided precision medicine design are 38% more likely to be commercialized. But success relies on following a plan from the start - learn how in this free whitepaper.
Exclusively designed for stakeholders within the diagnostics and research tool industry.
Always on the first day of MEDICA® in Dusseldorf!